Lilly Immergluck, MD, MS

2024 Senior Faculty Scholars

Lilly Cheng Immergluck is a physician-scientist who studies the impact of antibiotic-resistant infections and vaccine-preventable illnesses in children. Her research focuses on clinical vaccine and infectious disease–related therapeutic trials, and public health matters related to the prevention of infectious diseases among medically underserved populations, including how social determinants of health influence the spread of infection.

Her work has been published in Antibiotics, PLoS One, Nature Medicine, Journal of Infectious Diseases, Journal of Public Health Management and Practice, Clinical Infectious Diseases, JAMA Network Open, International Journal of Environmental Research and Public Health, and Pediatrics in Review.

Immergluck received her BA in biochemistry, molecular biology, and cell biology from Northwestern University, and an MD from The Ohio State University College of Medicine, followed by an MA in clinical research from Morehouse School of Medicine. She completed a residency in pediatrics and a fellowship in pediatric infectious diseases at the University of Chicago, where she received the Pediatric Scientist Development Award. Most recently, she was a professor and physician-scientist at Morehouse School of Medicine, as well as director of its Pediatric Clinical Translational Research and Vaccine Trial Units, and site principal investigator for its participation in the US Covid-19 Prevention Network.